Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

The complexities of head and neck cancers may be simpler than we thought

Importance of large database of genetic variants reinforced in a new study

Researchers discover new test that could change the diagnosis and treatment of prostate cancer

OICR researchers to be part of Cancer Research UK’s Grand Challenge helping to answer cancer’s biggest questions

New partnership brings Toronto researchers together to better understand the molecular origins of breast cancer

OICR invests in early-stage Ontario oncology drug development

Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research